Dr. John Easthope, MD

Cardiovascular Disease Pasadena, CA Male
NPI: 1174580328
Total Payments
$11,101
2024 Payments
$1,587
Companies
36
Transactions
601
Medicare Patients
2,615
Medicare Billing
$465,541

Payment Breakdown by Category

Food & Beverage$11,070 (99.7%)
Education$30.14 (0.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,070 599 99.7%
Education $30.14 2 0.3%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $2,053 113 $0 (2024)
Amgen Inc. $1,598 112 $0 (2024)
PFIZER INC. $1,145 64 $0 (2024)
Abbott Laboratories $930.60 42 $0 (2024)
SANOFI-AVENTIS U.S. LLC $506.23 27 $0 (2024)
E.R. Squibb & Sons, L.L.C. $492.99 32 $0 (2024)
AstraZeneca Pharmaceuticals LP $482.41 27 $0 (2024)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $429.82 31 $0 (2024)
Boston Scientific Corporation $423.19 20 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $364.08 18 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,587 76 Novartis Pharmaceuticals Corporation ($294.49)
2023 $1,381 64 Novartis Pharmaceuticals Corporation ($357.32)
2022 $1,288 69 Novartis Pharmaceuticals Corporation ($292.55)
2021 $1,007 54 Abbott Laboratories ($222.18)
2020 $839.41 48 Novartis Pharmaceuticals Corporation ($155.52)
2019 $1,612 88 Amgen Inc. ($476.10)
2018 $1,470 85 Amgen Inc. ($291.20)
2017 $1,915 117 Novartis Pharmaceuticals Corporation ($454.07)

All Payment Transactions

601 individual payment records from CMS Open Payments — Page 1 of 25

Date Company Product Nature Form Amount Type
12/20/2024 Medtronic, Inc. AZURE XT DR MRI SURESCAN (Device) Food and Beverage In-kind items and services $23.65 General
Category: Pacemakers
12/18/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $34.17 General
Category: Cardiology/Vascular Diseases
12/11/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $26.89 General
Category: DIABETES
12/06/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.33 General
Category: Cardiovascular and Metabolism
11/26/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $25.08 General
Category: DIABETES
11/18/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $1.86 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/15/2024 Boston Scientific Corporation EMBLEM MRI S-ICD (Device) Food and Beverage In-kind items and services $20.44 General
Category: EMBLEM_CRM
11/13/2024 Medtronic, Inc. LINQ II (Device) Food and Beverage In-kind items and services $29.08 General
Category: Cardiac Diagnostics and Monitoring
11/06/2024 Lexicon Pharmaceuticals, Inc. — Food and Beverage In-kind items and services $29.08 General
11/04/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $15.20 General
Category: Cardiology/Vascular Diseases
10/30/2024 Abbott Laboratories CARDIOMEMS (Device) Food and Beverage In-kind items and services $23.66 General
Category: Heart Failure
10/30/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $23.49 General
Category: CARDIOVASCULAR
10/29/2024 HEARTFLOW, INC. FFRct (Device) Food and Beverage Cash or cash equivalent $16.39 General
Category: Coronary
10/15/2024 Kiniksa Pharmaceuticals International, plc Arcalyst (Drug) Food and Beverage In-kind items and services $29.29 General
Category: Not Applicable
10/10/2024 Abbott Laboratories AVEIR (Device) Food and Beverage In-kind items and services $41.64 General
Category: Cardiac Rhythm Management
10/08/2024 Medtronic, Inc. TYRX (Device) Food and Beverage In-kind items and services $22.93 General
Category: Antibacterial Mesh
10/04/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $1.78 General
Category: Cardiology/Vascular Diseases
10/02/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $21.07 General
Category: CARDIOVASCULAR
09/30/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $17.33 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/04/2024 Medtronic, Inc. AURORA EV-ICD MRI SURESCAN (Device) Food and Beverage In-kind items and services $23.46 General
Category: Implant Cardio Defib - ICDs
08/27/2024 Lexicon Pharmaceuticals, Inc. — Food and Beverage In-kind items and services $32.40 General
08/26/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $19.10 General
Category: CARDIOVASCULAR
08/22/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $5.83 General
Category: Electromedical and Electrotherapeutic Apparatus
08/22/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $3.68 General
Category: Cardiology/Vascular Diseases
08/21/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $28.65 General
Category: Cardiovascular
123…25»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 556 1,057 $272,002 $103,991
2022 9 614 1,291 $323,637 $133,011
2021 9 639 1,226 $306,125 $130,132
2020 9 806 1,297 $257,535 $98,406
Total Patients
2,615
Total Services
4,871
Medicare Billing
$465,541
Procedure Codes
34

All Medicare Procedures & Services

34 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 206 649 $187,197 $88,239 47.1%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2023 62 63 $34,875 $4,821 13.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 42 46 $9,510 $4,748 49.9%
93351 Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report Office 2023 24 25 $9,500 $2,997 31.5%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 172 222 $24,420 $2,583 10.6%
93320 Ultrasound of heart blood flow, valves and chambers Office 2023 25 26 $2,860 $478.96 16.7%
93325 Ultrasound of heart with color-depicted blood flow, rate and valve function Office 2023 25 26 $3,640 $124.45 3.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 236 822 $226,050 $118,190 52.3%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2022 69 73 $38,970 $4,427 11.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 158 244 $26,840 $2,887 10.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 28 28 $5,460 $2,603 47.7%
93351 Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report Office 2022 33 33 $12,540 $2,056 16.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 13 13 $4,225 $1,482 35.1%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 11 12 $1,302 $839.37 64.5%
93320 Ultrasound of heart blood flow, valves and chambers Office 2022 33 33 $3,630 $437.35 12.0%
93325 Ultrasound of heart with color-depicted blood flow, rate and valve function Office 2022 33 33 $4,620 $90.50 2.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 239 751 $206,525 $112,126 54.3%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Office 2021 80 82 $43,050 $4,250 9.9%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 44 64 $6,720 $4,037 60.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 33 37 $7,215 $3,557 49.3%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 149 198 $21,780 $2,588 11.9%
93351 Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report Office 2021 27 27 $10,260 $1,763 17.2%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 11 11 $3,575 $1,347 37.7%
93320 Doppler ultrasound study of heart blood flow, valves, and chambers Office 2021 28 28 $3,080 $394.50 12.8%
93325 Doppler ultrasound study of color-directed heart blood flow, rate, and valve function Office 2021 28 28 $3,920 $68.25 1.7%
12»

About Dr. John Easthope, MD

Dr. John Easthope, MD is a Cardiovascular Disease healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174580328.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Easthope, MD has received a total of $11,101 in payments from pharmaceutical and medical device companies, with $1,587 received in 2024. These payments were reported across 601 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($11,070).

As a Medicare-enrolled provider, Easthope has provided services to 2,615 Medicare beneficiaries, totaling 4,871 services with total Medicare billing of $465,541. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Location Pasadena, CA
  • Active Since 04/28/2006
  • Last Updated 11/04/2011
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1174580328

Products in Payments

  • ENTRESTO (Drug) $1,394
  • ELIQUIS (Drug) $1,175
  • Repatha (Biological) $819.55
  • Corlanor (Drug) $778.37
  • LEQVIO (Drug) $659.11
  • LifeVest (Device) $429.82
  • PRALUENT (Drug) $365.47
  • XARELTO (Drug) $358.38
  • VYNDAQEL (Drug) $343.72
  • JARDIANCE (Drug) $308.14
  • FARXIGA (Drug) $279.97
  • NEXLETOL (Drug) $242.92
  • Vascepa (Drug) $208.51
  • Confirm Rx (Device) $172.47
  • Arcalyst (Drug) $159.82
  • AMVUTTRA (Drug) $148.25
  • MULTAQ (Drug) $140.76
  • AVEIR (Device) $133.41
  • OPTIMIZER (Device) $128.86
  • VERQUVO (Drug) $120.10

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Pasadena

Dr. Mayer Rashtian, M.d, M.D

Cardiovascular Disease — Payments: $260,147

Cardiovascular Disease $260,147

Dr. Azhil Durairaj, Md, MD

Cardiovascular Disease — Payments: $42,986

Cardiovascular Disease $42,986

Nikhil Daga, Md, MD

Cardiovascular Disease — Payments: $26,876

Cardiovascular Disease $26,876

David Hamer, Md, MD

Cardiovascular Disease — Payments: $24,855

Cardiovascular Disease $24,855

Gregory Giesler, Md, MD

Cardiovascular Disease — Payments: $17,996

Cardiovascular Disease $17,996

Dr. Tishangi Agrawal, Md, MD

Cardiovascular Disease — Payments: $11,870

Cardiovascular Disease $11,870